PRES following administration of DHE in a patient with unsuspected pheochromocytoma

Headache

Volumn 48, Issue 8, 2008, Pages 1237-1239

  Kelley, Brendan J ^a   Samples, Stephen ^b   Kunkel, Robert ^b  

^a MAYO CLINIC   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Balint syndrome; Dihydroergotamine; Pheochromocytoma; Posterior reversible encephalopathy syndrome

Indexed keywords

DIHYDROERGOTAMINE; LISINOPRIL; METADRENALIN; METHYLPREDNISOLONE; NAPROXEN; NARCOTIC ANALGESIC AGENT; NITROPRUSSIDE SODIUM; ROFECOXIB;

ADULT; ARTICLE; BALINT SYDROME; CASE REPORT; CLUSTER HEADACHE; DIFFUSION WEIGHTED IMAGING; FLUSHING; FOLLOW UP; HEART PALPITATION; HUMAN; HYPERTENSION; KIDNEY MASS; LEUKOENCEPHALOPATHY; MALE; NEUROLOGIC EXAMINATION; PHEOCHROMOCYTOMA; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PRIORITY JOURNAL; SEIZURE; SWEATING; SYMPTOMATOLOGY; URINALYSIS;

ADULT; ANALGESICS, NON-NARCOTIC; DIHYDROERGOTAMINE; HEADACHE; HUMANS; HYPERTENSIVE ENCEPHALOPATHY; MALE; PHEOCHROMOCYTOMA; SEIZURES; VISION DISORDERS;

EID: 51249111480     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2008.01154.x     Document Type: Article

References (11)

1. Bravo EL, Tagle R. Pheochromocytoma state-of-the-art and future prospects. Endocr Rev. 2003 24 : 539 553.
2. Kudva YC, Sawka AM, Young WF Jr. Clinical review 164: The laboratory diagnosis of adrenal pheochromocytoma: The Mayo Clinic experience. J Clin Endocrinol Metab. 2003 88 : 4533 4539.
3. Mellander S, Nordenfelt I. Comparative effects of dihydroergotamine and noradrenaline on resistance, exchange and capacitance functions in the peripheral circulation. Clin Sci. 1970 39 : 183 201.
4. Goadsby PJ, Gundlach AL. Localization of 3H-dihydroergotamine-binding sites in the cat central nervous system: Relevance to migraine. Ann Neurol. 1991 29 : 91 94.
5. Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996 334 : 494 500.
6. Provenzale JM, Petrella JR, Cruz LC, et al. Quantitative assessment of diffusion abnormalities in posterior reversible encephalopathy syndrome. AJNR. 2001 22 : 1455 1461.
7. Covarrubias DJ, Luetmer PH, Campeau NG. Posterior reversible encephalopathy syndrome: Prognostic utility of quantitative diffusion-weighted MR images. AJNR. 2002 23 : 1038 1048.
8. Ay H, Buonanno FS, Schaefer PW, et al. Posterior leukoencephalopathy without severe hypertension: Utility of diffusion-weighted MRI. Neurology. 1998 51 : 1369 1376.
9. Edvinsson L, Owman C, Sjoberg NO. Autonomic nerves, mast cells, and amine receptors in human brain vessels. A histochemical and pharmacological study. Brain Res. 1976 115 : 377 393.
10. Sheth RD, Riggs JE, Bodenstenier JB, Gutierrez AR, Ketonen LM, Ortiz OA. Parietal occipital edema in hypertensive encephalopathy: A pathogenic mechanism. Eur Neurol. 1996 36 : 25 28.
11. Schwartz RB, Mulkern RV, Gudbjartsson H, Jolesz F. Diffusion-weighted MR imaging in hypertensive encephalopathy: Clues to pathogenesis. AJNR. 1998 19 : 859 862.